Cigna Corporation

🇺🇸New York Stock Exchange
Back to all articles
Cigna Corporation stock analysis CI overview
Bullish +75

The Cigna Group (CI) Stock Analysis: Uncovering A Promising 21.93% Upside Potential - DirectorsTalk Interviews

📈 Analysts project an average target price of $340.50, implying a 21.93% upside potential from the current trading price of $279.27.

💰 The company reports strong financial health with revenue growth of 4.60%, EPS of $24.99, and free cash flow of $6.92 billion.

📊 Valuation appears attractive with a forward P/E ratio of 8.35 and a return on equity (ROE) of 16.27%.

💵 Cigna offers a sustainable dividend yield of 2.23% backed by a conservative payout ratio of 24.36%.

👍 Analyst sentiment is highly positive with 20 buy ratings and no sell recommendations among the 24 analysts covering the stock.

📉 Technical indicators show the stock hovering near its 50-day moving average with an RSI of 38.02, suggesting potential oversold conditions.

🏢 The company operates through two main segments: Evernorth Health Services and Cigna Healthcare, focusing on pharmacy benefit management and care services.

🌍 Founded in 1792 and headquartered in Bloomfield, Connecticut, the group recently rebranded to reflect its global commitment to innovative health solutions.

Bullish Signals
  • Analysts set an average target price of $340.50, indicating a significant 21.93% upside potential from the current stock price.
  • The company demonstrates strong profitability with a return on equity (ROE) of 16.27% and revenue growth of 4.60%.
  • Cigna generates impressive free cash flow of $6.92 billion, providing ample liquidity for strategic initiatives and shareholder returns.
  • Analyst sentiment is overwhelmingly bullish, with 20 out of 24 analysts issuing buy ratings and zero sell recommendations.
  • The forward P/E ratio of 8.35 suggests the stock may be undervalued relative to its future earnings potential.
  • Cigna offers a sustainable dividend yield of 2.23% with a low payout ratio of 24.36%, supporting income investors.
Full Analysis
The Cigna Group (NYSE: CI) is a major player in the healthcare sector with a market capitalization of $73.88 billion. Currently trading at $279.27, the stock has dipped slightly but maintains resilience within its 52-week range of $244.41 to $334.39. Analysts project an average target price of $340.50, suggesting a potential upside of approximately 21.93% from current levels. Financial metrics indicate strong operational efficiency with revenue growth of 4.60% and earnings per share (EPS) of $24.99. The company boasts an attractive forward P/E ratio of 8.35, a return on equity (ROE) of 16.27%, and robust free cash flow of $6.92 billion. These figures provide flexibility for reinvestment, debt reduction, or dividend payments. Cigna offers a sustainable dividend yield of 2.23% with a conservative payout ratio of 24.36%. Analyst sentiment is overwhelmingly positive, with 20 out of 24 covering analysts issuing buy ratings and no sell recommendations. The company's dual-segment structure, comprising Evernorth Health Services and Cigna Healthcare, positions it to capitalize on growing demand for comprehensive healthcare solutions.